T cells engineered with a T cell receptor against the prostate antigen TARP specifically kill HLA-A2+ prostate and breast cancer cells

Development of Novel Immune Interventions for Prostate Cancer

(2012) Neeraj Agarwal et al.   Clinical Genitourinary Cancer

Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia

(2011) David L. Porter et al.   NEW ENGLAND JOURNAL OF MEDICINE

T Cells with Chimeric Antigen Receptors Have Potent Antitumor Effects and Can Establish Memory in Patients with Advanced Leukemia

(2011) M. Kalos et al.   Science Translational Medicine

Antibody responses to galectin-8, TARP and TRAP1 in prostate cancer patients treated with a GM-CSF-secreting cellular immunotherapy

(2010) Minh C. Nguyen et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Targeting TARP, a novel breast and prostate tumor-associated antigen, with T cell receptor-like human recombinant antibodies

(2008) Malka Epel et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

High frequency of prostate antigen-directed T cells in cancer patients compared to healthy age-matched individuals

(2008) Ole Forsberg et al.   PROSTATE